Humana Q3 top line up 9%; EPS up 13%; CF Ops up 8%; GAAP earnings guidance lowered

• Humana (NYSE:HUM) Q3 results ($M): Total Revenues: 13,363 (+9.2%); Premiums: 12,987 (+11.9%); Services: 246 (-54.1%); Investment Income: 130 (+36.8%).
• Net Income: 314 (+8.3%); EPS: 2.09 (+13.0%); Non-GAAP EPS: 2.16 (+16.8%); CF Ops: 1.03B (+8.2%).
• Consolidated benefit Expense Ratio: 83.9% (+0.7%); Total Medical Membership: 14,210.1 (0%).
• Generic Dispense Rate: 89.5% (+1.4%); Script Volume: 100,600 (+20.5%).
• 2015 Guidance: EPS: $9.18 from $9.28; Non-GAAP EPS: $7.75 (unch).